Aslan Pharmaceuticals Pte Ltd
- Address
- 3 Temasek Avenue
Sponsor Overview
Specializations
Dermatology
ASLAN Pharmaceuticals focuses its clinical research on atopic dermatitis, with attention to patients living with persistent inflammatory skin disease and ongoing symptom burden.
- Moderate-to-severe atopic dermatitis
- Inflammatory skin disorders
- Chronic pruritic disease
The sponsor’s current research activity is centered on treatment options for individuals who have previously received dupilumab, reflecting interest in difficult-to-manage dermatologic disease.
Immunology
The company’s trial portfolio is directed toward immune-mediated skin inflammation, with emphasis on pathways relevant to eczema and related immune dysregulation.
- Immune-mediated inflammation
- Skin barrier dysfunction
- Allergic inflammation
Its research activity is aligned with conditions where immune signaling contributes to persistent cutaneous symptoms and disease severity.
Biologic Therapy
ASLAN Pharmaceuticals is involved in clinical evaluation of biologic therapy for chronic inflammatory disease, with a focus on targeted treatment approaches in dermatology.
- Targeted immunomodulation
- Monoclonal antibody therapy
- Advanced therapeutic antibodies
The sponsor’s research interest lies in therapies designed to address patients whose disease remains active despite prior advanced treatment.
Refractory Disease Management
Its clinical work includes patients with treatment-experienced atopic dermatitis, highlighting interest in disease that has not been adequately controlled by earlier therapy.
- Prior biologic exposure
- Persistent disease activity
- Unmet dermatologic need
This area reflects attention to individuals requiring additional therapeutic options after previous systemic treatment.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Efficacy and Safety Evaluation of Eblasakimab in Moderate-to-Severe Atopic Dermatitis Patients Previously Treated with Dupilumab: A Randomized, Double-Blind, Placebo-Controlled Trial |  Germany Poland | Not Yet Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 9 sites across their trial portfolio.
Therapeutic Focus
- 1.Skin and Connective Tissue Diseases1 trial247 other sponsors
Partnered Research Centres
9 centres- Address
- Pck 26 Street, 33-100 Tarnow
- Address
- Plac Szczepanski 3, 31-011 Krakow
- Address
- Hindenburgdamm 30, Lichterfelde, 12203 Berlin
- Address
- Ul. Ul. Sliczna 13, 50-566 Wroclaw
- Address
- Ul. Sokolowska 9/u2, 01-142 Warsaw
- Address
- Am Krankenhaus 1, 21614 Buxtehude
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Aslan Pharmaceuticals Pte Ltd.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.